logo

For the Inventor, By the Inventor

Ness Ziona, Israel

Prochon Biotech Ltd.


USPTO Granted Patents = 17

% Expired Patents = 52.9



Forward Citations = 1,708

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Avner Yayon (17 out of 30 patents)

silverMedal Oren Bogin (7 out of 7 patents)

bronzeMedal Malkit Azachi (4 out of 10 patents)

4.  Micha Gladnikoff (3 out of 3 patents)

5.  Eran Rom (2 out of 8 patents)

6.  Irina Chumakov (2 out of 2 patents)

7.  Sara Blumenstein (2 out of 3 patents)

8.  Boaz Amit (2 out of 4 patents)

9.  Avraham Wortzel (2 out of 3 patents)

10.  Hilla Barkay (1 out of 1 patent)

11.  Rivka Adar (1 out of 1 patent)

12.  Myriam Golembo (1 out of 1 patent)

13.  Moshe Peretz (1 out of 1 patent)

14.  Yigal Burstein (1 out of 4 patents)

15.  Rachel Glicklis (1 out of 1 patent)


17 patents:

1. 9862753 - FGF-2 variants having N-terminal deletions and increased receptor selectivity and methods of use thereof (2018-01-09),
2. 9487568 - FGF-2 variants and methods of use thereof (2016-11-08),
3. 8962556 - FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof (2015-02-24),
4. 8940888 - Hydrazido derivatives of hyaluronic acid (2015-01-27),
5. 8916522 - FGF-9 variants and methods of use thereof (2014-12-23),
6. 8618258 - Freeze-dried fibrin matrices and methods for preparation thereof (2013-12-31),
7. 8609823 - FGF-9 variants and methods for use thereof (2013-12-17),
8. 8524885 - Hydrazido derivatives of hyaluronic acid (2013-09-03),
9. 8193317 - Freeze-dried fibrin matrices and methods for preparation thereof (2012-06-05),
10. 8119783 - FGF variants and methods for use thereof (2012-02-21),
11. 7714107 - Freeze-dried fibrin matrices and methods for preparation thereof (2010-05-11),
12. 7563769 - FGF variants and methods for use thereof (2009-07-21),
13. 7335508 - Porous plasma protein matrices and methods for preparation thereof (2008-02-26),
14. 7288406 - Active variants of FGF with improved specificity (2007-10-30),
15. 7276481 - Method and composition for treatment of skeletal dysplasias (2007-10-02),
Company Overview
Prochon Biotech Ltd. is a biotechnology company based in Ness Ziona, Israel, specializing in the development of innovative therapies for regenerative medicine. The company focuses on harnessing advanced cell-based technologies to create solutions for various medical conditions, particularly in the fields of tissue engineering and cellular therapies. Prochon Biotech is committed to advancing healthcare through its research and development efforts, aiming to improve patient outcomes and quality of life.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#6 in Ness Ziona

#374 in Israel

#35,948 in the World

Ness Ziona, IL
Ness Ziona, Israel

Prochon Biotech Ltd.

Forward Citations = 1,708

15 inventors:

goldMedal Avner Yayon (17 out of 30 patents)

silverMedal Oren Bogin (7 out of 7 patents)

bronzeMedal Malkit Azachi (4 out of 10 patents)

4.  Micha Gladnikoff (3 out of 3 patents)

5.  Eran Rom (2 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Prochon Biotech Ltd.. Retrieved from https://idiyas.com/company/prochon-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…